Loading company details...
Latest Form 4 (Nov 13, 2026): Gregory L. Weaver (Chief Financial Officer): Purchase of 10,000 shares, $16.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Gregory L. Weaver, Chief Financial Officer | Purchase | 10,000 | $16.2K |
| Nov 13, 2026 | Wayne Pisano | Purchase | 10,000 | $16.4K |
| Nov 13, 2026 | Jerome Benedict Durso, President and CEO | Purchase | 30,700 | $49.7K |
| Nov 13, 2026 | Gregory L. Weaver, Chief Financial Officer | Exercise/Conversion | 18,750 | n/a |
| Nov 4, 2026 | Peter Greenleaf | Grant/Award | 160,000 | n/a |
| Nov 4, 2026 | Alex G. Howarth | Grant/Award | 160,000 | n/a |
| Oct 5, 2026 | Christophe Arbet-Engels, Chief Medical Officer | Exercise/Conversion | 37,500 | n/a |
| Oct 5, 2026 | Gregory L. Weaver, Chief Financial Officer | Exercise/Conversion | 14,475 | n/a |
| Oct 2, 2026 | Richard Thomas Menziuso, Principal Accounting Officer | Grant/Award | 84,546 | n/a |
| Sep 17, 2026 | Linda M. Richardson, Chief Commercial Officer | Exercise/Conversion | 24,000 | n/a |